Literature DB >> 24422039

Organic nitrates for osteoporosis: an update.

Celeste J Hamilton1, Lauren S Reid2, Sophie A Jamal3.   

Abstract

The number of osteoporotic fractures is increasing worldwide as populations age. An inexpensive and widely available treatment is necessary to alleviate this increase in fractures. Current treatments decrease fractures at trabecular bone sites (spine) but have limited effects at cortical sites (hip, legs, forearm and upper arm)-the most common sites of osteoporotic fracture. Treatments are also limited by costs, side effects and lack of availability. Nitric oxide (NO) is a novel agent that has the potential to influence cortical bone, is inexpensive, widely available and has limited side effects. In this review, we will evaluate the in vitro and in vivo data that support the concept that NO is important in bone cell function, review the observational, case control and randomized trial data on organic nitrates and the effects of these agents on bone turnover, geometry and strength.

Entities:  

Year:  2013        PMID: 24422039      PMCID: PMC3722720          DOI: 10.1038/bonekey.2012.259

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  45 in total

1.  Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats.

Authors:  C H Turner; Y Takano; I Owan; G A Murrell
Journal:  Am J Physiol       Date:  1996-04

Review 2.  The Michael Mason Prize Essay 1997. Nitric oxide and bone: what a gas!

Authors:  S H Ralston
Journal:  Br J Rheumatol       Date:  1997-08

3.  Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.

Authors:  Sophie A Jamal; Celeste J Hamilton; Richard Eastell; Steven R Cummings
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

4.  Pharmacokinetics of nitroglycerin and long-acting nitrate esters.

Authors:  H L Fung
Journal:  Am J Med       Date:  1983-06-27       Impact factor: 4.965

5.  Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system.

Authors:  P Collin-Osdoby; L Li; L Rothe; F Anderson; D Kirsch; M J Oursler; P Osdoby
Journal:  J Bone Miner Res       Date:  1998-01       Impact factor: 6.741

6.  Effects of nitric oxide synthase inhibitors on bone formation in rats.

Authors:  C H Turner; I Owan; D S Jacob; R McClintock; M Peacock
Journal:  Bone       Date:  1997-12       Impact factor: 4.398

7.  Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.

Authors:  Marc C Hochberg; Susan Greenspan; Richard D Wasnich; Paul Miller; Desmond E Thompson; Philip D Ross
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

8.  Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures.

Authors:  S A Jamal; W S Browner; D C Bauer; S R Cummings
Journal:  J Bone Miner Res       Date:  1998-11       Impact factor: 6.741

9.  Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial.

Authors:  Sophie A Jamal; Steven R Cummings; Gillian A Hawker
Journal:  J Bone Miner Res       Date:  2004-07-26       Impact factor: 6.741

10.  Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study.

Authors:  M Rosselli; B Imthurn; P J Keller; E K Jackson; R K Dubey
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

View more
  3 in total

1.  A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.

Authors:  Hema Kalyanaraman; Ghania Ramdani; Jisha Joshua; Nadine Schall; Gerry R Boss; Esther Cory; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  J Bone Miner Res       Date:  2016-09-07       Impact factor: 6.741

2.  Inhibition of MSTN signal pathway may participate in LIPUS preventing bone loss in ovariectomized rats.

Authors:  Liang Tang; Yiting Kang; Shuxin Sun; Tingting Zhao; Wenxin Cao; Xiushan Fan; Jianzhong Guo; Lijun Sun; Dean Ta
Journal:  J Bone Miner Metab       Date:  2019-08-14       Impact factor: 2.626

3.  Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass.

Authors:  Se-Min Kim; Charit Taneja; Helena Perez-Pena; Vitaly Ryu; Anisa Gumerova; Wenliang Li; Naseer Ahmad; Ling-Ling Zhu; Peng Liu; Mehr Mathew; Funda Korkmaz; Sakshi Gera; Damini Sant; Elina Hadelia; Kseniia Ievleva; Tan-Chun Kuo; Hirotaka Miyashita; Li Liu; Irina Tourkova; Sarah Stanley; Daria Lizneva; Jameel Iqbal; Li Sun; Ronald Tamler; Harry C Blair; Maria I New; Shozeb Haider; Tony Yuen; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.